Joanne Holland
Fortune : 84 000 $ au 31/08/2026
Fortune : 84 000 $ au 31/08/2026
Joanne Holland was the founder of Nuformix Plc, founded in 2008, serving as Executive Director in 2021.
Dr. Holland is currently the Chief Scientific Officer at CDT Equity, Inc., starting in 2024.
Formerly, Director, Chief Scientific & Technology Officer at Nuformix Technologies Ltd. from 2008 to 2021.
Education includes a doctorate from the University of Leeds.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUFORMIX PLC 1,44 % | 28/01/2025 | 37 500 000 ( 1,44 % ) | 84 000 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CDT EQUITY INC. | Directeur Technique/Scientifique/R&D | 19/03/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Technique/Scientifique/R&D | 31/05/2021 |
| NUFORMIX PLC | Fondateur | 31/05/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nuformix Plc
Nuformix Plc BiotechnologyHealth Technology Develops commercial technologies in pharmaceutical and biotechnology sector | Health Technology |
Conduit Pharmaceuticals, Inc.
Conduit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty biopharmaceutical company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national